We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSNY icon
3601
Polestar Automotive Holding UK
PSNY
$1.97B
$116K ﹤0.01%
730
+242
+50% +$39.2K
GSAT icon
3602
Globalstar
GSAT
$10.8B
$116K ﹤0.01%
5,821
+2,320
+66% +$61K
LAZR
3603
DELISTED
Luminar Technologies
LAZR
$116K ﹤0.01%
1,559
+47
+3% +$5.12K
SPFF icon
3604
Global X SuperIncome Preferred ETF
SPFF
$142M
$115K ﹤0.01%
12,243
-1,657
-12% -$16.1K
METC icon
3605
Ramaco Resources Class A
METC
$681M
$115K ﹤0.01%
13,520
-10,493
-44% -$106K
CTRA
3606
CALL
DELISTED
Coterra Energy
CTRA
$115K ﹤0.01%
+69,400
New +$1.91M
MRO
3607
PUT
DELISTED
Marathon Oil Corporation
MRO
$115K ﹤0.01%
+168,500
New +$4.89M
SLI
3608
Standard Lithium
SLI
$596M
$114K ﹤0.01%
38,647
-110,043
-74% -$425K
MRSN
3609
DELISTED
Mersana Therapeutics
MRSN
$114K ﹤0.01%
+777
New +$131K
DBI icon
3610
Designer Brands
DBI
$315M
$113K ﹤0.01%
11,592
-5,142
-31% -$69.3K
RKT icon
3611
Rocket Companies
RKT
$39.2B
$113K ﹤0.01%
16,143
-19,121
-54% -$140K
JRS icon
3612
Nuveen Real Estate Income Fund
JRS
$243M
$112K ﹤0.01%
14,873
-7,115
-32% -$55.8K
MFIN icon
3613
Medallion Financial
MFIN
$253M
$112K ﹤0.01%
15,725
HWM icon
3614
CALL
Howmet Aerospace
HWM
$113B
$111K ﹤0.01%
10,300
MAMA icon
3615
Mama's Creations
MAMA
$827M
$110K ﹤0.01%
61,500
NHS
3616
Neuberger High Yield Strategies Fund Inc
NHS
$255M
$110K ﹤0.01%
12,891
-3,181
-20% -$26.7K
UP icon
3617
Wheels Up
UP
$196M
$109K ﹤0.01%
530
-36
-6% -$9.28K
NCV
3618
Virtus Convertible & Income Fund
NCV
$391M
$109K ﹤0.01%
8,026
+239
+3% +$3.34K
OCUL icon
3619
Ocular Therapeutix
OCUL
$2.27B
$108K ﹤0.01%
38,470
-18,955
-33% -$62.8K
ONL
3620
Orion Office REIT
ONL
$157M
$108K ﹤0.01%
12,646
-1,349
-10% -$12.3K
STNE icon
3621
StoneCo
STNE
$2.38B
$107K ﹤0.01%
11,383
+1,030
+10% +$10.8K
GOGL
3622
DELISTED
Golden Ocean Group
GOGL
$106K ﹤0.01%
+12,224
New +$106K
ABST
3623
DELISTED
Absolute Software Corp
ABST
$106K ﹤0.01%
10,150
NVS icon
3624
PUT
Novartis
NVS
$291B
$106K ﹤0.01%
+29,000
New +$2.44M
IMMR icon
3625
Immersion
IMMR
$244M
$104K ﹤0.01%
14,807

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.